Company & Sponsor Intelligence

Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed1

Countries2

Therapeutic footprint

alzheimersdepressionother_psychiatry

Indexed studies

NCT01949571Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.
depression · MexicoPHASE2

NCT03270137Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease
alzheimers · NA

NCT06019247Individual Placement and Support Mexico
other_psychiatry · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →